{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:03:36Z","timestamp":1775171016445,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.urology.2022.01.044","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T10:56:22Z","timestamp":1645008982000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-5100","authenticated-orcid":false,"given":"Stacy H.","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn T.","family":"Werneburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Abouassaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadley","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.01.044_bib0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41585-019-0274-3","article-title":"Tumour innervation and neurosignalling in prostate cancer","volume":"17","author":"March","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0002","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science (80-)"},{"key":"10.1016\/j.urology.2022.01.044_bib0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science (80-)"},{"key":"10.1016\/j.urology.2022.01.044_bib0004","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1541-7786.MCR-17-0132","article-title":"Sympathetic signaling reactivates quiescent disseminated prostate cancer cells in the bone marrow","volume":"15","author":"Decker","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.urology.2022.01.044_bib0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.urology.2003.10.022","article-title":"Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients","volume":"63","author":"Scott","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.01.044_bib0006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pmrj.2011.04.024","article-title":"Prevalence of prostate cancer in patients with chronic spinal cord injury","volume":"3","author":"Patel","year":"2011","journal-title":"PM R"},{"key":"10.1016\/j.urology.2022.01.044_bib0007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/aja.aja_31_18","article-title":"Risk of prostate cancer in men with spinal cord injury: a systematic review and meta-analysis","volume":"20","author":"Barbonetti","year":"2018","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urology.2022.01.044_bib0008","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0009","unstructured":"Final Recommendation Statement: Prostate Cancer: Screening | United States Preventive Services Taskforce. Available at:https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/document\/RecommendationStatementFinal\/prostate-cancer-screening. Accessed February 2, 2021."},{"key":"10.1016\/j.urology.2022.01.044_bib0010","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/nau.21119","article-title":"PSA levels in men with spinal cord injury and under intermittent catheterization","volume":"30","author":"Torricelli","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2022.01.044_bib0011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0012","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.urology.2018.01.005","article-title":"Spina bifida health-care guidelines for men's health","volume":"116","author":"Wiener","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.01.044_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.juro.2018.02.3101","article-title":"Bladder management and continence outcomes in adults with spina bifida: results from the national spina bifida patient registry, 2009 to 2015","volume":"200","author":"Wiener","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000056005","article-title":"Spina bifida outcome: a 25-year prospective","volume":"34","author":"Bowman","year":"2001","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.urology.2022.01.044_bib0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.sc.3100628","article-title":"Mortality following spinal cord injury","volume":"36","author":"Yeo","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.urology.2022.01.044_bib0016","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2015.61.6532","article-title":"National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen-Based screening","volume":"33","author":"Drazer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2022.01.044_bib0017","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3122\/jabfm.2015.04.150062","article-title":"Decrease in prostate cancer testing following the US Preventive Services Task Force (USPSTF) recommendations","volume":"28","author":"Li","year":"2015","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.urology.2022.01.044_bib0018","first-page":"e3","article-title":"Factors related to use of prostate cancer screening: the Alberta Tomorrow Project","volume":"1","author":"Richardson","year":"2007","journal-title":"Open Med"},{"key":"10.1016\/j.urology.2022.01.044_bib0019","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/21681805.2020.1797871","article-title":"PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing","volume":"54","author":"Enblad","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sc.2017.38","article-title":"Health care utilization in persons with spinal cord injury: part 2-determinants, geographic variation and comparison with the general population","volume":"55","author":"Ronca","year":"2017","journal-title":"Spinal Cord"},{"key":"10.1016\/j.urology.2022.01.044_bib0021","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000001763","article-title":"Racial disparities in prostate specific antigen screening and referral to urology in a large, integrated health care system: a retrospective cohort study","volume":"206","author":"Lu","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0022","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.juro.2015.11.023","article-title":"Determinants of prostate specific antigen screening among black men in the United States in the contemporary era","volume":"195","author":"Sammon","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djab072","article-title":"The impact of intensifying prostate cancer screening in black men: a model-based analysis","author":"Nyame","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2022.01.044_bib0024","doi-asserted-by":"crossref","unstructured":"Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level \u22644.0 ng per milliliter. 2009; 350: 2239\u20132246. http:\/\/dx.doi.org\/10.1056\/NEJMoa031918","DOI":"10.1056\/NEJMoa031918"},{"key":"10.1016\/j.urology.2022.01.044_bib0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0090-4295(03)00654-X","article-title":"Prostate size and PSA serum levels in male patients with spinal cord injury","volume":"62","author":"Pannek","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.01.044_bib0026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0090-4295(00)00548-3","article-title":"Evaluation of the effect of spinal cord injury on serum PSA levels","volume":"56","author":"Konety","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.01.044_bib0027","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0022-5347(05)65286-X","article-title":"Prostate cancer screening with prostate specific antigen in spinal cord injured men","volume":"167","author":"Pramudji","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0028","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.01.044_bib0029","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis?","volume":"179","author":"Feliciano","year":"2008","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:45:09Z","timestamp":1758768309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S0090429522001418"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.01.044","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}